News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
582,401 Results
Type
Article (39589)
Company Profile (312)
Press Release (542500)
Multimedia
Podcasts (67)
Webinars (11)
Section
Business (164438)
Career Advice (2395)
Deals (29632)
Drug Delivery (104)
Drug Development (77606)
Employer Resources (142)
FDA (14056)
Job Trends (12611)
News (290050)
Policy (27693)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2594)
Accelerated approval (6)
Adcomms (26)
Allergies (82)
Alliances (41879)
ALS (94)
Alzheimer's disease (1433)
Antibody-drug conjugate (ADC) (139)
Approvals (14047)
Artificial intelligence (249)
Autoimmune disease (26)
Automation (15)
Bankruptcy (320)
Best Places to Work (10405)
BIOSECURE Act (16)
Biosimilars (95)
Biotechnology (255)
Bladder cancer (72)
Brain cancer (28)
Breast cancer (275)
Cancer (2166)
Cardiovascular disease (186)
Career advice (2013)
Career pathing (32)
CAR-T (149)
Cell therapy (419)
Cervical cancer (18)
Clinical research (62929)
Collaboration (805)
Compensation (369)
Complete response letters (24)
COVID-19 (2513)
CRISPR (43)
C-suite (249)
Cystic fibrosis (99)
Data (2088)
Decentralized trials (2)
Denatured (15)
Depression (51)
Diabetes (257)
Diagnostics (5651)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (40)
Drug discovery (123)
Drug pricing (100)
Drug shortages (22)
Duchenne muscular dystrophy (98)
Earnings (60785)
Editorial (38)
Employer branding (19)
Employer resources (130)
Events (87843)
Executive appointments (723)
FDA (15215)
Featured Employer (42)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (722)
Gene editing (108)
Generative AI (20)
Gene therapy (317)
GLP-1 (727)
Government (4164)
Grass and pollen (5)
Guidances (49)
Healthcare (16843)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (130)
Indications (29)
Infectious disease (2654)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (48)
Intellectual property (90)
Interviews (518)
IPO (13964)
IRA (45)
Job creations (2638)
Job search strategy (1648)
Kidney cancer (11)
Labor market (21)
Layoffs (446)
Leadership (21)
Legal (5765)
Liver cancer (73)
Lung cancer (321)
Lymphoma (140)
Machine learning (6)
Management (52)
Manufacturing (276)
MASH (71)
Medical device (10799)
Medtech (10803)
Mergers & acquisitions (16160)
Metabolic disorders (680)
Multiple sclerosis (77)
NASH (22)
Neurodegenerative disease (100)
Neuropsychiatric disorders (34)
Neuroscience (1985)
NextGen: Class of 2025 (5727)
Non-profit (3961)
Northern California (2360)
Now hiring (36)
Obesity (359)
Opinion (233)
Ovarian cancer (73)
Pain (84)
Pancreatic cancer (78)
Parkinson's disease (154)
Partnered (20)
Patents (221)
Patient recruitment (103)
Peanut (47)
People (53259)
Pharmaceutical (55)
Pharmacy benefit managers (12)
Phase I (19824)
Phase II (27870)
Phase III (20663)
Pipeline (1135)
Policy (136)
Postmarket research (2289)
Preclinical (8287)
Press Release (59)
Prostate cancer (99)
Psychedelics (37)
Radiopharmaceuticals (254)
Rare diseases (396)
Real estate (4303)
Recruiting (55)
Regulatory (19799)
Reports (25)
Research institute (2193)
Resumes & cover letters (346)
Rett syndrome (4)
RNA editing (4)
RSV (40)
Schizophrenia (74)
Series A (127)
Series B (82)
Service/supplier (2)
Sickle cell disease (54)
Southern California (2098)
Special edition (13)
Spinal muscular atrophy (151)
Sponsored (28)
Startups (3079)
State (2)
Stomach cancer (14)
Supply chain (59)
Tariffs (28)
The Weekly (51)
United States (20495)
Vaccines (639)
Venture capitalists (39)
Weight loss (244)
Women's health (26)
Worklife (16)
Date
Today (40)
Last 7 days (614)
Last 30 days (2220)
Last 365 days (30837)
2025 (9302)
2024 (33065)
2023 (36979)
2022 (47771)
2021 (51255)
2020 (49043)
2019 (41378)
2018 (31213)
2017 (28932)
2016 (27373)
2015 (32041)
2014 (24526)
2013 (19718)
2012 (20882)
2011 (21843)
2010 (19719)
Location
Africa (713)
Alabama (53)
Alaska (4)
Arizona (166)
Arkansas (12)
Asia (35453)
Australia (7092)
California (5453)
Canada (1879)
China (483)
Colorado (239)
Connecticut (231)
Delaware (138)
Europe (79342)
Florida (806)
Georgia (179)
Idaho (51)
Illinois (463)
India (23)
Indiana (254)
Iowa (8)
Japan (151)
Kansas (91)
Kentucky (20)
Louisiana (10)
Maine (52)
Maryland (820)
Massachusetts (4065)
Michigan (198)
Minnesota (336)
Mississippi (2)
Missouri (79)
Montana (24)
Nebraska (22)
Nevada (53)
New Hampshire (63)
New Jersey (1575)
New Mexico (25)
New York (1533)
North Carolina (903)
North Dakota (5)
Northern California (2360)
Ohio (172)
Oklahoma (10)
Oregon (32)
Pennsylvania (1172)
Puerto Rico (11)
Rhode Island (29)
South America (974)
South Carolina (18)
South Dakota (1)
Southern California (2098)
Tennessee (88)
Texas (783)
Utah (166)
Virginia (129)
Washington D.C. (55)
Washington State (508)
West Virginia (3)
Wisconsin (45)
582,401 Results for "apim therapeutics as".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA desires to share more information with the Company’s shareholders about the proposed merger between the Company and APIM Therapeutics.
November 21, 2022
·
6 min read
Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics
Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”) today announces an update following the Extraordinary General Meeting held on 1 December at which the proposed merger transaction with APIM Therapeutics AS (“APIM”) did not obtain a sufficient majority of votes and was therefore voted down.
December 9, 2022
·
2 min read
Deals
Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA has today launched a new dedicated area on its website ( www.nordicnanovector.com ) with information in Norwegian for shareholders relating to its proposed merger with APIM Therapeutics (“APIM”).
November 25, 2022
·
6 min read
Deals
Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics
Nordic Nanovector ASA will host a webcast, including a question and answers session on Thursday, November 24 at 4.30 P.M. CET.
November 23, 2022
·
3 min read
Press Releases
Verismo Therapeutics Announces Poster Presentation at ASCO 2025
April 24, 2025
·
3 min read
Press Releases
Adcentrx Therapeutics to Present First Clinical Data for ADRX-0706 Nectin-4 ADC at ASCO 2025
April 23, 2025
·
4 min read
Press Releases
Obsidian Therapeutics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
April 25, 2025
·
3 min read
Press Releases
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
April 16, 2025
·
2 min read
Press Releases
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress
April 15, 2025
·
5 min read
Press Releases
Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025
April 23, 2025
·
2 min read
1 of 58,241
Next
